Loading news...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference.
HeartBeam's FDA clearance for its cable-free at-home 12-lead ECG marks a pivotal step toward commercialization and broader cardiac-care adoption.
HeartBeam, Inc.'s (NASDAQ: BEAT) stock is trading higher on Monday, with a session volume of 193.38 million compared to the average volume of 2.191 million as per data from Benzinga Pro.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment.
HeartBeam shares jumped 40.75% in after-hours trading after the company outlined its regulatory strategy following the FDA's Not Substantially Equivalent decision.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application.
HeartBeam, Inc. ( BEAT ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Robert Eno - CEO, Chief Business Officer & Director Timothy Cruickshank - Chief Financial Officer Conference Call Participants Kyle Bauser - ROTH Capital Partners, LLC, Research Division William Sutherland - The Benchmark Company, LLC, Research Division Presentation Operator Greetings, and welcome to the HeartBeam Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Third Quarter 2025 Results.
DENVER , Nov. 3, 2025 /PRNewswire/ -- SM Energy Company (the "Company") (NYSE: SM) today reported financial and operating results for the third quarter 2025 and provided certain full year and fourth quarter 2025 guidance. Highlights include: Strong Production Performance Continues: Production totaled 19.7 MMBoe, or 213.8 MBoe/d, including 113.9 MBbls/d of oil driven by consistent strong performance across all assets.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Third Quarter 2025 Results Conference Call on Thursday, November 13, 2025 at 4:30 p.m. Eastern Time.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Teams Up With HeartNexus to Deliver Cardiologist-Level ECG Insights Anytime, Anywhere.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam's Deep Learning Algorithms Demonstrate High Rates of Accuracy for Detecting Arrhythmias.
HeartBeam, Inc. (NASDAQ:BEAT ) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Ian Scargill - Corporate Participant Robert P. Eno - CEO, Chief Business Officer & Director Timothy Cruickshank - Chief Financial Officer Conference Call Participants William Sutherland - The Benchmark Company, LLC, Research Division Operator Greetings, and welcome to the HeartBeam Second Quarter 2025 Financial Results Conference Call.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Second Quarter 2025 Results.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Second Quarter 2025 Results Conference Call on Wednesday, August 13, 2025 at 4:30 p.m. Eastern Time.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Wins Industry Innovation Award for Advancing Remote Cardiac Care with Groundbreaking ECG Technology.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025.
HeartBeam, Inc. (NASDAQ:BEAT ) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Rob Eno - CEO Tim Cruickshank - CFO Larry Holub - IR, MZ Group Conference Call Participants Bill Sutherland - The Benchmark Company Leo Carpio - Joseph Gunnar Operator Greetings and welcome to the HeartBeam First Quarter 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode.